858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small molecule drugs that act on novel therapeutic targets in oncology.
858 was founded by a veteran team who together bring a track record of success in pharma and biotech drug discovery. Building from our collective experience in the fields of epigenetics, single cell genomics, and innate immunity, 858 scientists are dedicated to the company’s mission to discover innovative therapeutics for the treatment of cancers that are resistant to current therapies.
858 is headquartered in the biotech hub of San Diego, CA, and maintains lab operations in both San Diego and New York City, providing proximity to leading investigators and scientific talent on both coasts of the US.
Company Details
- Employees
- 24
- Founded
- -
- Address
- 3115 Merryfield Row, San Diego,california 92121,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.8five8tx.com
- Keywords
- San Diego.
- HQ
- San Diego, California
858 Therapeutics Questions
858 Therapeutics's website is http://www.8five8tx.com
858 Therapeutics's LinkedIn profile is https://www.linkedin.com/company/858-therapeutics
858 Therapeutics has
24 employees.
View email and phone details for 24
employees at 858 Therapeutics.
858 Therapeutics's industry is
Biotechnology Research
858 Therapeutics's top competitors are
Circle Pharma, Inc.,
Cue Biopharma,
Longbio Pharma,
Orsobio,
Genespire,
Gc Therapeutics,
Nura Bio,
Splitero,
Vironexis Biotherapeutics,
Nalu Medical, Inc..
858 Therapeutics's categories are Biotechnology Research
858 Therapeutics's founding year is 2019
